Zentalis Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.61

+0.57 (+14.11%)

As of Jun 29, 10:17 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 9 60%

Hold 6 40%

Sell 0 0%

Price Target

Analyst Price Target +487.6% upside

Low Target $17.95

Average Target $27.09

High Target $27.14

Current Price $4.61

Current
$4.61

Target
$27.09

$17.95 $27.09 avg $27.14

Scenario Analysis

Bear Case

$17.95

289.4%

Low target

Base Case

$27.09

+487.6%

Avg target

Bull Case

$27.14

+488.7%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$6.95

-33.7% from high

52-Week Low

$1.13

+308.0% from low

Target vs 52W High

$27.09

+289.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%